Inflammatory Markers Predict Survival in Patients With Advanced Gastric and Colorectal Cancers Receiving Anti–PD-1 Therapy

Inflammatory Markers Predict Survival in Patients With Advanced Gastric and Colorectal Cancers Receiving Anti–PD-1 Therapy

There is a lack of useful biomarkers for predicting the efficacy of anti–programmed death-1 (PD-1) therapy for advanced gastric and colorectal cancer. To address this issue, in this study we investigated the correlation between inflammatory marker expression and survival in patients with advanced ga...

Full description

Bibliographic Details
Main Authors: Xiaona Fan, Dan Wang, Wenjing Zhang, Jinshuang Liu, Chao Liu, Qingwei Li, Zhigang Ma, Hengzhen Li, Xin Guan, Yibing Bai, Jiani Yang, Changjie Lou, Xiaobo Li, Guangyu Wang, Zhiwei Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
anti–PD-1 therapy
inflammatory biomarker
advanced gastric and colorectal cancer
response
PFS
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2021.638312/full

Internet

https://www.frontiersin.org/articles/10.3389/fcell.2021.638312/full

Similar Items